Published ahead of print on May 29, 2008, doi:10.1164/rccm.200711-1648OC
Am. J. Respir. Crit. Care Med., Volume 178, Number 4, August 2008, 379-388
A more recent version of this article appeared on August 15, 2008
Submitted on November 7, 2007
Accepted on May 29, 2008
Interferon Regulates Idiopathic Pneumonia Syndrome, A Th17+CD4+ T-cell-mediated GvH Disease
Nora Mauermann1, Julia Burian1, Christophe von Garnier1, Stefan Dirnhofer2, Davide Germano1, Christine Schuett3, Michael Tamm4, Roland Bingisser5, Urs Eriksson1, and Lukas Hunziker1*
1 Experimental Critical Care Medicine, Departments of Research and Internal Medicine, University Hospital, Basel, Switzerland,
2 Department of Pathology, University Hospital, Basel, Switzerland,
3 Institut for Immunology and Transfusionsmedicine, Ernst-Moritz-Arndt-University, Greifswald, Germany,
4 Department of Respiratory Medicine, University Hospital, Basel, Switzerland,
5 Emergency Department, University Hospital, Basel, Switzerland
* To whom correspondence should be addressed. E-mail: lhunziker{at}uhbs.ch.
Rationale: Pulmonary complications of hematopoietic stem cell transplantation include infections and graft-versus-host diseases, such as idiopathic pneumonia syndrome (IPS). Conflicting data exist regarding the role of the
interferon-gamma-producing Th1 CD4+ T-cell subset and IL-17A in IPS.
Objectives: To determine the role of interferon-gamma (IFN- ) and IL-17A in the establishment of pulmonary graft-versus-host disease.
Methods: A semi-allogeneic model based on C57BL/6 x BALB/c as recipients with transplantation of BALB/c RAG2-/- bone marrow and transfer of different genetic knockout T cells (T-bet-/-, IFN- -/-, IFN- R-/-) on a BALB/c background. Lung tissue was examined for parenchymal changes and infiltrating cells by histology and FACS analysis.
Main results: After transfer of semi-allogeneic bone marrow together with donor CD4+ T cells lacking IFN- or T-bet-a T-box transcription factor controlling Th1 commitment- we found severe inflammation in the lungs, but no enhancement in other organs. In contrast, wild-type donor CD4+ T cells mediated minimal inflammation only, and donor CD8++ T cells were not required for IPS development. Mechanistically, the absence of IFN- or IFN- signaling in pulmonary parenchymal cells promoted expansion of IL-17A producing CD4+ T cells and local IL-17A release. In vivo depletion of IL-17A reduced disease severity.
Conclusions: One mechanism of IFN- protection against IPS is negative regulation of the expansion of pathogenic IL-17A-producing CD4+ T cells through interaction with the IFN- receptor on the pulmonary parenchymal cell population.
Key words: idiopathic pneumonia syndrome, graft versus host disease, CD4 T cells, IL-17, antigen presenting cells
This article has been cited by other articles:

|
 |

|
 |
 
T. Yi, Y. Chen, L. Wang, G. Du, D. Huang, D. Zhao, H. Johnston, J. Young, I. Todorov, D. T. Umetsu, et al.
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease
Blood,
October 1, 2009;
114(14):
3101 - 3112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, W. Asavaroengchai, B. Yong Yeap, M.-G. Wang, S. Wang, M. Sykes, and Y.-G. Yang
Paradoxical effects of IFN-{gamma} in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury
Blood,
April 9, 2009;
113(15):
3612 - 3619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Behr and V. J. Thannickal
Update in Diffuse Parenchymal Lung Disease 2008
Am. J. Respir. Crit. Care Med.,
March 15, 2009;
179(6):
439 - 444.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Carlson, M. L. West, J. M. Coghill, A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Blood,
February 5, 2009;
113(6):
1365 - 1374.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 American Thoracic Society
|
|
|